Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 5Genitourinary 2Thoracic 1Other 1NET 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Melanoma 8Lymphoma, T-Cell, Cutaneous 6Waldenstrom Macroglobulinemia 5Leukemia, Lymphocytic, Chronic, B-Cell 5Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Anaplastic 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Lymphoma 4Immunoblastic Lymphadenopathy 4Sezary Syndrome 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms, Plasma Cell 3Mycosis Fungoides 3Multiple Myeloma 3Hodgkin Disease 3Burkitt Lymphoma 3Somatostatinoma 2Skin Neoplasms 2Lymphoma, T-Cell 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Extranodal NK-T-Cell 2Insulinoma 2Glucagonoma 2Carcinoma, Merkel Cell 2Carcinoma, Medullary 2Zollinger-Ellison Syndrome 1

Interventions

vatalanib 1temsirolimus 1pentetreotide 1antineoplaston AS 2-1 1antineoplaston A10 1Vinorelbine 1Sirolimus 1Melphalan 1High-Energy Shock Waves 1Fentanyl 1Everolimus 1Complementary Therapies 1Biological Therapy 190Y-octreotide, DOTA-Tyr(3)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Islet Cell × Everolimus × Dermatologic × Clear all
NCT00655655 2024-08-21

Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors

Mayo Clinic

Phase 1 Completed
96 enrolled
DermatologicEndocrineGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Glucagonoma, Insulinoma, Melanoma, Pheochromocytoma, Somatostatinoma, Carcinoma, Merkel Cell, Gastrinoma, Carcinoma, Islet Cell, Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡